Results 121 to 130 of about 9,430 (168)

Beyond Monotherapy: Exploring the Efficacy and Safety of Dual Biologic Strategies in Rheumatic Diseases. [PDF]

Biologics
Hassan F, Jeries H, Daood R, Naffaa ME.
europepmc   +1 more source

Irritable Bowel Syndrome Prevalence in Patients with Inflammatory Bowel Disease in Remission: Single-Center Experience. [PDF]

Clin Exp Gastroenterol
Golubovic O, Knezevic Ivanovski T, Kralj D, Mitrovic M, Milić A, Svorcan P, Markovic S.   +6 more
europepmc   +1 more source

Impact of Adherence to Golimumab on Disease Flares in Rheumatoid Arthritis: Results from a Canadian Observational Study. [PDF]

Patient Prefer Adherence
Bessette L, Boulos P, Arendse R, Rahman P, Aseer S, Ruban T, Rachich M, Nantel F, Calce A, Asin-Milan O, Haaland D.   +10 more
europepmc   +1 more source

European Medicines Agency approvals of new medicines in September and October 2025. [PDF]

Lancet Reg Health Eur
Sepodes B, Burgos JG, Thirstrup S.
europepmc   +1 more source

Incidence rates of tuberculosis and inflammatory bowel disease in patients with ankylosing spondylitis treated with biologics in Korea. [PDF]

Rheumatology (Oxford)
Kwon OC, Lee HS, Yang J, Paul T, Jin H, Lee Y, Park MC.   +6 more
europepmc   +1 more source

Exploring biomarkers for treatment response in psoriatic arthritis: a focus on multi-omics technologies. [PDF]

Pharmacogenomics J
Khasru MR, Abdul Jalil NA, Nair N, Barton A, Martin P, Ho P, Bluett J.   +6 more
europepmc   +1 more source

Risk of new-onset and recurrent uveitis with different biologics for ankylosing spondylitis: a network meta-analysis. [PDF]

Front Immunol
Zhao X, Xie Q, He X, Lu Y, Li M, Shuai S.   +5 more
europepmc   +1 more source